Logo image
Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn
Journal article   Peer reviewed

Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn

M. Galbally, S. Gentile and A.J. Lewis
CNS Drugs, Vol.26(10), pp.813-822
2012
url
Link to Published Version *Subscription may be requiredView

Abstract

Persistent pulmonary hypertension of the newborn (PPHN) is a rare but potentially life-threatening neonatal condition. Several authors have suggested that late pregnancy exposure to selective serotonin reuptake inhibitors (SSRIs) may increase the risk of PPHN. This association has been investigated in seven published studies that have shown mixed findings based on diverse methods. Several methodological limitations may account for the diversity of findings, which include, in some studies, a lack of control for well established risk factors for PPHN. The methodological improvement in the most recent study tentatively suggests that infants prenatally exposed to SSRIs are approximately twice as likely to suffer PPHN. Further research on the biological mechanisms involved is required. Clinicians should consider late pregnancy exposure to SSRIs as one of several possible risks for PPHN, which has implications for both prescribing SSRIs to pregnant women and for neonatal care of SSRI-exposed infants.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
#5 Gender Equality

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.72 Obstetrics & Gynecology
1.72.1072 Perinatal Mental Health
Web Of Science research areas
Clinical Neurology
Pharmacology & Pharmacy
Psychiatry
ESI research areas
Neuroscience & Behavior
Logo image